Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Orenstein

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Therapeutic Advances in Gastroenterology|November 17, 2025
Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent <i>Clostridioides difficile</i> infection from five prospective clinical trials: an updateChristine Lee, Paul Feuerstadt, Thomas Louie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2015
Coccidioidal Tenosynovitis of the Hand and Wrist: Report of 9 Cases and Review of the LiteratureMark Campbell, Shimon Kusne, Kevin J Renfree, et al.
Inflammatory Bowel Diseases|December 11, 2019
Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel DiseaseRaseen Tariq, Molly B Disbrow, John K Dibaise, et al.
Gastroenterology|February 26, 2008
Risk factors for opportunistic infections in patients with inflammatory bowel diseaseMurat Toruner, Edward V Loftus, W Scott Harmsen, et al.
Diagnostic Microbiology and Infectious Disease|September 25, 2009
High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severityBrandon P Verdoorn, Robert Orenstein, Jon E Rosenblatt, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 6, 2022
Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 ReinfectionIsin Yagmur Comba, Irene Riestra Guiance, Cristina Corsini Campioli, et al.
The American Journal of Gastroenterology|November 24, 2011
The epidemiology of community-acquired Clostridium difficile infection: a population-based studySahil Khanna, Darrell S Pardi, Scott L Aronson, et al.
Infection Control and Hospital Epidemiology|June 4, 2008
Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapyBrandon P Verdoorn, Robert Orenstein, John W Wilson, et al.
Emerging Infectious Diseases|May 29, 2014
Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosisJanis E Blair, Yu-Hui H Chang, Meng-Ru Cheng, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIALZelalem Temesgen, Charles D Burger, Jason Baker, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Therapeutic Advances in Gastroenterology|November 17, 2025
Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent <i>Clostridioides difficile</i> infection from five prospective clinical trials: an updateChristine Lee, Paul Feuerstadt, Thomas Louie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2015
Coccidioidal Tenosynovitis of the Hand and Wrist: Report of 9 Cases and Review of the LiteratureMark Campbell, Shimon Kusne, Kevin J Renfree, et al.
Inflammatory Bowel Diseases|December 11, 2019
Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel DiseaseRaseen Tariq, Molly B Disbrow, John K Dibaise, et al.
Gastroenterology|February 26, 2008
Risk factors for opportunistic infections in patients with inflammatory bowel diseaseMurat Toruner, Edward V Loftus, W Scott Harmsen, et al.
Diagnostic Microbiology and Infectious Disease|September 25, 2009
High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severityBrandon P Verdoorn, Robert Orenstein, Jon E Rosenblatt, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 6, 2022
Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 ReinfectionIsin Yagmur Comba, Irene Riestra Guiance, Cristina Corsini Campioli, et al.
The American Journal of Gastroenterology|November 24, 2011
The epidemiology of community-acquired Clostridium difficile infection: a population-based studySahil Khanna, Darrell S Pardi, Scott L Aronson, et al.
Infection Control and Hospital Epidemiology|June 4, 2008
Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapyBrandon P Verdoorn, Robert Orenstein, John W Wilson, et al.
Emerging Infectious Diseases|May 29, 2014
Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosisJanis E Blair, Yu-Hui H Chang, Meng-Ru Cheng, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIALZelalem Temesgen, Charles D Burger, Jason Baker, et al.
Pageof 9